Fidelity Investments’s Bioceres Crop Solutions BIOX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-1
Closed -$8 5555
2024
Q3
$8 Sell
1
-10
-91% -$101 ﹤0.01% 5440
2024
Q2
$123 Hold
11
﹤0.01% 4953
2024
Q1
$139 Hold
11
﹤0.01% 4944
2023
Q4
$151 Hold
11
﹤0.01% 4907
2023
Q3
$124 Hold
11
﹤0.01% 4830
2023
Q2
$147 Hold
11
﹤0.01% 4929
2023
Q1
$128 Hold
11
﹤0.01% 4882
2022
Q4
$132 Sell
11
-18
-62% -$234 ﹤0.01% 4858
2022
Q3
$0 Buy
+29
New +$356 ﹤0.01% 4856

Other funds holding BIOX

Fidelity Investments's BIOX Position: Q4 2024 in Review

Fidelity Investments sold out of Bioceres Crop Solutions (BIOX) in Q4 2024, closing a stake of 1 share — an estimated $8 sold.

Fidelity Investments first reported a position in BIOX in Q3 2022 and held it in 9 quarters. The position peaked at $151 in Q4 2023. 43 funds tracked by Wall St. Rank hold BIOX as of Q4 2024.

  • Fidelity Investments reported no remaining Bioceres Crop Solutions position as of Q4 2024 after selling out during the quarter.
  • Fidelity Investments sold 1 Bioceres Crop Solutions share in Q4 2024, an estimated $8.
  • Fidelity Investments first reported a position in Bioceres Crop Solutions in Q3 2022 and held it in 9 quarters.
  • Fidelity Investments's Bioceres Crop Solutions position peaked at $151 in Q4 2023.
  • 43 funds tracked by Wall St. Rank held Bioceres Crop Solutions as of Q4 2024.

Based on Fidelity Investments's 13F filing for Q4 2024, filed 13 Feb 2025.